ADAMTS13 deficiency and immunological abnormalities in patients with systemic sclerosis

Zofia Gerlicz-Kowalczuk; Jolanta D. Torzecka; Elżbieta Dziankowska-Zaborszczyk; Alicja Ograczyk; Anna M. Zalewska-Janowska; Anna Woźnicka; Bożena Dziankowska-Bartkowiak

doi:10.5114/ada.2018.75240

eISSN: 2299-0046
ISSN: 1642-395X

Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii

Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

2/2018
vol. 35

Send email

Copy url:

abstract:

Original paper

ADAMTS13 deficiency and immunological abnormalities in patients with systemic sclerosis

Zofia Gerlicz-Kowalczuk

,

Jolanta D. Torzecka

,

Elżbieta Dziankowska-Zaborszczyk

,

Alicja Ograczyk

,

Anna M. Zalewska-Janowska

,

Anna Woźnicka

,

Bożena Dziankowska-Bartkowiak

Adv Dermatol Allergol 2018; XXXV (2): 182–184

DOI: https://doi.org/10.5114/ada.2018.75240

Online publish date: 2018/04/24

View full text Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Gerlicz-Kowalczuk Z, Torzecka J, Dziankowska-Zaborszczyk E, et al. ADAMTS13 deficiency and immunological abnormalities in patients with systemic sclerosis. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2018;35(2):182-184. doi:10.5114/ada.2018.75240.

APA

Gerlicz-Kowalczuk, Z., Torzecka, J., Dziankowska-Zaborszczyk, E., Ograczyk, A., Zalewska-Janowska, A.,  & Woźnicka, A. et al. (2018). ADAMTS13 deficiency and immunological abnormalities in patients with systemic sclerosis. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 35(2), 182-184. https://doi.org/10.5114/ada.2018.75240

Chicago

Gerlicz-Kowalczuk, Zofia, Jolanta D. Torzecka, Elżbieta Dziankowska-Zaborszczyk, Alicja Ograczyk, Anna M. Zalewska-Janowska, Anna Woźnicka,  and Bożena Dziankowska-Bartkowiak. 2018. "ADAMTS13 deficiency and immunological abnormalities in patients with systemic sclerosis". Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii 35 (2): 182-184. doi:10.5114/ada.2018.75240.

Harvard

Gerlicz-Kowalczuk, Z., Torzecka, J., Dziankowska-Zaborszczyk, E., Ograczyk, A., Zalewska-Janowska, A., Woźnicka, A.,  and Dziankowska-Bartkowiak, B. (2018). ADAMTS13 deficiency and immunological abnormalities in patients with systemic sclerosis. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 35(2), pp.182-184. https://doi.org/10.5114/ada.2018.75240

MLA

Gerlicz-Kowalczuk, Zofia et al. "ADAMTS13 deficiency and immunological abnormalities in patients with systemic sclerosis." Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, vol. 35, no. 2, 2018, pp. 182-184. doi:10.5114/ada.2018.75240.

Vancouver

Gerlicz-Kowalczuk Z, Torzecka J, Dziankowska-Zaborszczyk E, Ograczyk A, Zalewska-Janowska A, Woźnicka A et al. ADAMTS13 deficiency and immunological abnormalities in patients with systemic sclerosis. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2018;35(2):182-184. doi:10.5114/ada.2018.75240.

Introduction
Systemic sclerosis (SSc) is a chronic autoimmune connective tissue disorder characterized by immunological deviations and generalized microvascular damage.

Aim
To determine the serum level of the von Willebrand factor cleaving protease (ADAMTS13) in 39 SSc patients and healthy controls.

Material and methods
ADAMTS13 serum level was determined in 39 SSc patients and 11 healthy controls. Complete history of the patients was recorded and thorough clinical, rheumatological, and dermatological examinations were performed.

Results
The serum levels of ADAMTS13 were significantly lower in SSc than in normal controls (455.47 ±128 vs. 702.01 ±142 ng/ml, p < 0.00001). However significant correlations among serum ADAMTS 13 levels and organ changes were not found in SSc patients.

Conclusions
We demonstrate a decreased serum level of ADAMTS13 in SSc patients, which may contribute to the vessel microangiopathy observed in systemic sclerosis.

keywords:

ADAMTS13 deficiency and immunological abnormalities in patients with systemic sclerosis

Zofia Gerlicz-Kowalczuk , Jolanta D. Torzecka , Elżbieta Dziankowska-Zaborszczyk , Alicja Ograczyk , Anna M. Zalewska-Janowska , Anna Woźnicka , Bożena Dziankowska-Bartkowiak

systemic sclerosis, ADAMTST13

Zofia Gerlicz-Kowalczuk

,

Jolanta D. Torzecka

,

Elżbieta Dziankowska-Zaborszczyk

,

Alicja Ograczyk

,

Anna M. Zalewska-Janowska

,

Anna Woźnicka

,

Bożena Dziankowska-Bartkowiak